
BAY32-5915
CAS No. 1571-30-8
BAY32-5915( 8-Hydroxyquinoline-2-carboxylic acid )
Catalog No. M27330 CAS No. 1571-30-8
BAY32-5915 is a selective inhibitor of IKKalpha.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | 35 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBAY32-5915
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY32-5915 is a selective inhibitor of IKKalpha.
-
DescriptionBAY32-5915 is a selective inhibitor of IKKalpha.
-
In VitroBAY32-5915 (50-200 μM) has no significant inhibitory effect on NF-κB activity in melanoma cells.
-
In Vivo——
-
Synonyms8-Hydroxyquinoline-2-carboxylic acid
-
PathwayImmunology/Inflammation
-
TargetIκB kinase (IKK)
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1571-30-8
-
Formula Weight189.17
-
Molecular FormulaC10H7NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (660.78 mM)
-
SMILESOC(=O)c1ccc2cccc(O)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog



related products
-
IKK-16 (IKK Inhibito...
IKK-16 (IKK Inhibitor VII) is a selective IκB kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively.
-
MLN120B
MLN120B is a selective and ATP competitive IKKβ inhibitor (IC50: 60 nM).MLN120B almost completely blocks the stimulation of MM.1S, U266, and INA6 cell growth, as well as IL-6 secretion from BMSCs, induced by multiple myeloma cell adherence to BMSCs [1]. MLN120B shows an inhibitory effect on LPS induced NF-κB activation in RAW267.4 cells.
-
ACHP
ACHP (IKK-2 Inhibitor VIII) is a novel selective and potent IKK inhibitor with inhibitory effects on IKK-α and IKK-β.